Anxiety disorders in a neuromuscular clinic

Area of Science:

• Neurology
• Psychiatry
• Clinical Psychology

Background:

• Myasthenia gravis (MG) and polymyositis/dermatomyositis (PM/DM) are autoimmune disorders affecting muscle function.
• Anxiety disorders, including panic disorder and agoraphobia, are common comorbidities in various medical conditions.
• The relationship between neuromuscular disorders and psychological distress warrants further investigation.

Purpose of the Study:

• To assess the prevalence of anxiety disorders in patients diagnosed with myasthenia gravis (MG) and polymyositis/dermatomyositis (PM/DM).
• To compare the rates of specific anxiety disorders, particularly panic disorder/agoraphobia, between the two patient groups.
• To explore potential links between the symptomatology of MG and the development of panic disorder/agoraphobia.

Main Methods:

• A structured interview was administered to assess psychiatric conditions.
• Participants included 20 patients with myasthenia gravis and 15 patients with polymyositis/dermatomyositis.
• Diagnostic criteria were applied to identify anxiety disorders.

Main Results:

• Fifteen out of 35 patients (43%) received a diagnosis of an anxiety disorder.
• A significantly higher proportion of myasthenia gravis patients (40%) were diagnosed with panic disorder/agoraphobia compared to polymyositis/dermatomyositis patients (7%).
• No significant difference was noted in the overall anxiety disorder diagnosis rate between the two groups, but panic disorder/agoraphobia was notably higher in MG patients.

Conclusions:

• The symptoms associated with myasthenia gravis may increase the risk for developing panic disorder/agoraphobia in susceptible individuals.
• These findings highlight the importance of screening for anxiety disorders in patients with myasthenia gravis.
• Further research is recommended to elucidate the underlying mechanisms connecting myasthenia gravis and panic disorder/agoraphobia.